PTGX 8-K 2026-01-12

Protagonist Therapeutics, Inc (PTGX) 8-K dated 2026-01-12 — accession 0001104659-26-002724. This URL is the filing, not the PTGX hub.

Protagonist Therapeutics, Inc (PTGX) is a biotechnology company listed on NASDAQ.

Protagonist Therapeutics, Inc filed a 8-K on 2026-01-12. Accession 0001104659-26-002724.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.

Not investment advice. The PTGX SEC hub lists recent forms. The stock page is the research view.